The Belgian Brain Council Forum focused on a key question: How can we enable patients to benefit from therapeutic innovation while ensuring the sustainability and equity of our healthcare system?

 

Through six concrete examples of neurological diseases—ranging from migraine to other conditions where innovation is transforming clinical practice—clinicians, researchers, and policymakers weighed the benefits of new treatments against the challenges posed by their cost and accessibility.

 

The morning concluded with a candid roundtable discussion: Can reimbursement keep pace with innovation?